Year 2020 has been set as the delivery date for 500,000 whole exome sequences from the UK Biobank cohorts.
First functioning human muscle grown from induced pluripotent stem cells holds promise for cellular therapies, drug discovery and studying rare diseases.
Newly described stretches of super-silenced DNA reveal a fresh approach to reprogram cell identity to use in regenerative medicine studies and one day in the clinic.
Researchers have created a method for implanting hundreds of thousands of insulin-producing pancreatic cell clusters into diabetes patients to help manage the disease.
New study published in Nature has provided compelling evidence that acetaldehyde; a breakdown product of ethanol could cause dramatic damage to DNA and an increased risk of cancer.
Black and white people have the same risk of developing diabetes when all biological factors for the disease are considered over time, according to a new study.
23andMe have announced a large-scale study designed to uncover the genetic reasons why people respond differently to diet and exercise regimes.
Eating Less Chocolate in 2018? You Might Want to Reconsider as Your Favourite Treat Could Be Extinct by 2050
If your New Year’s Resolution was to give up chocolate, you might find it easier to do it in 2050, when scientists suspect chocolate may go extinct.
Unless, that is, gene-editing scientists manage to save it.
A drug developed for type 2 diabetes has “significantly reversed memory loss” in mice with Alzheimer’s disease, and researchers now want to test it on humans.
It seems there’s some work to do as the “vast majority” of NHS doctors are “not up to speed” with modern genetic techniques that can transform patients’ survival chances, a Government adviser has warned.
Women diagnosed with restless leg syndrome had a 43% higher likelihood of death due to cardiovascular disease during a ten-year period, in new study.